市場調査レポート

商品コード

ドラベ症候群治療の世界市場 2025～2029年

Global Dravet Syndrome Treatment Market 2025-2029

出版日: 2025年05月29日
発行: TechNavio
ページ情報: 英文 222 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,200円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,320円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ドラベ症候群治療市場は2024-2029年に8億4,950万米ドル、予測期間中のCAGRは11.4％で成長すると予測されます。

当レポートでは、ドラベ症候群治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、特別な規制指定の増加、新製品上市の増加、ドラベ症候群治療のための遺伝子治療薬の進歩によって牽引されています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比	10.1%
CAGR	11.4%
増分額	8億4,950万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間におけるドラベ症候群治療市場の成長を促進する主な要因の一つとして、新世代の薬剤の使用増加を挙げています。また、生物医学の進歩と強力なパイプラインは、市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
アジア：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
メキシコ：市場規模と予測 2024-2029
市場機会：地域情勢別

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
AbbVie Inc.
BIOCODEX SAS
Encoded Therapeutics Inc.
Epygenix Therapeutics Inc.
H Lundbeck AS
Jazz Pharmaceuticals Plc
Johnson and Johnson Services Inc.
Lupin Ltd.
PTC Therapeutics Inc.
Stoke Therapeutics Inc.
Sun Pharmaceutical Industries Ltd.
Supernus Pharmaceuticals Inc.
Takeda Pharmaceutical Co. Ltd.
UCB SA
Viatris Inc.

第16章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibits7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on SGDs - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on SGDs - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on SGDs - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on SGDs - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on TGDs - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on TGDs - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on TGDs - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on TGDs - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on FGDs - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on FGDs - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on FGDs - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on FGDs - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Chart on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits57: Data Table on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Diagnostic Methods
Exhibits59: Data Table on Comparison by Diagnostic Methods
Exhibits60: Chart on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Electroencephalography - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Electroencephalography - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Electroencephalography - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Diagnostic Methods ($ million)
Exhibits77: Data Table on Market opportunity by Diagnostic Methods ($ million)
Exhibits78: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits79: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by Distribution Channel
Exhibits81: Data Table on Comparison by Distribution Channel
Exhibits82: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on E-commerce - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
Exhibits94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits98: Market opportunity by Distribution Channel ($ million)
Exhibits99: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits103: Chart on Geographic comparison
Exhibits104: Data Table on Geographic comparison
Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits158: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits159: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits161: Market opportunity By Geographical Landscape ($ million)
Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits163: Impact of drivers and challenges in 2024 and 2029
Exhibits164: Overview on criticality of inputs and factors of differentiation
Exhibits165: Overview on factors of disruption
Exhibits166: Impact of key risks on business
Exhibits167: Companies covered
Exhibits168: Company ranking index
Exhibits169: Matrix on companies position and classification
Exhibits170: AbbVie Inc. - Overview
Exhibits171: AbbVie Inc. - Product / Service
Exhibits172: AbbVie Inc. - Key news
Exhibits173: AbbVie Inc. - Key offerings
Exhibits174: SWOT
Exhibits175: BIOCODEX SAS - Overview
Exhibits176: BIOCODEX SAS - Product / Service
Exhibits177: BIOCODEX SAS - Key offerings
Exhibits178: SWOT
Exhibits179: Encoded Therapeutics Inc. - Overview
Exhibits180: Encoded Therapeutics Inc. - Product / Service
Exhibits181: Encoded Therapeutics Inc. - Key offerings
Exhibits182: SWOT
Exhibits183: Epygenix Therapeutics Inc. - Overview
Exhibits184: Epygenix Therapeutics Inc. - Product / Service
Exhibits185: Epygenix Therapeutics Inc. - Key offerings
Exhibits186: SWOT
Exhibits187: H Lundbeck AS - Overview
Exhibits188: H Lundbeck AS - Product / Service
Exhibits189: H Lundbeck AS - Key offerings
Exhibits190: SWOT
Exhibits191: Jazz Pharmaceuticals Plc - Overview
Exhibits192: Jazz Pharmaceuticals Plc - Product / Service
Exhibits193: Jazz Pharmaceuticals Plc - Key news
Exhibits194: Jazz Pharmaceuticals Plc - Key offerings
Exhibits195: SWOT
Exhibits196: Johnson and Johnson Services Inc. - Overview
Exhibits197: Johnson and Johnson Services Inc. - Business segments
Exhibits198: Johnson and Johnson Services Inc. - Key news
Exhibits199: Johnson and Johnson Services Inc. - Key offerings
Exhibits200: Johnson and Johnson Services Inc. - Segment focus
Exhibits201: SWOT
Exhibits202: Lupin Ltd. - Overview
Exhibits203: Lupin Ltd. - Business segments
Exhibits204: Lupin Ltd. - Key news
Exhibits205: Lupin Ltd. - Key offerings
Exhibits206: Lupin Ltd. - Segment focus
Exhibits207: SWOT
Exhibits208: PTC Therapeutics Inc. - Overview
Exhibits209: PTC Therapeutics Inc. - Product / Service
Exhibits210: PTC Therapeutics Inc. - Key offerings
Exhibits211: SWOT
Exhibits212: Stoke Therapeutics Inc. - Overview
Exhibits213: Stoke Therapeutics Inc. - Product / Service
Exhibits214: Stoke Therapeutics Inc. - Key offerings
Exhibits215: SWOT
Exhibits216: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits217: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits218: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits219: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits220: SWOT
Exhibits221: Supernus Pharmaceuticals Inc. - Overview
Exhibits222: Supernus Pharmaceuticals Inc. - Product / Service
Exhibits223: Supernus Pharmaceuticals Inc. - Key offerings
Exhibits224: SWOT
Exhibits225: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits226: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits227: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits228: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits229: SWOT
Exhibits230: UCB SA - Overview
Exhibits231: UCB SA - Product / Service
Exhibits232: UCB SA - Key offerings
Exhibits233: SWOT
Exhibits234: Viatris Inc. - Overview
Exhibits235: Viatris Inc. - Business segments
Exhibits236: Viatris Inc. - Key news
Exhibits237: Viatris Inc. - Key offerings
Exhibits238: Viatris Inc. - Segment focus
Exhibits239: SWOT
Exhibits240: Inclusions checklist
Exhibits241: Exclusions checklist
Exhibits242: Currency conversion rates for US$
Exhibits243: Research methodology
Exhibits244: Information sources
Exhibits245: Data validation
Exhibits246: Validation techniques employed for market sizing
Exhibits247: Data synthesis
Exhibits248: 360 degree market analysis
Exhibits249: List of abbreviations

Product Code: IRTNTR45344

The dravet syndrome treatment market is forecasted to grow by USD 849.5 mn during 2024-2029, accelerating at a CAGR of 11.4% during the forecast period. The report on the dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for ds treatment.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	10.1%
CAGR	11.4%
Incremental Value	$849.5 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's dravet syndrome treatment market is segmented as below:

By Product

SGDs
TGDs
FGDs

By Diagnostic Methods

Magnetic resonance imaging
Electroencephalography
SCN1A genetic testing
Others

By Distribution Channel

Hospital pharmacy
Retail pharmacy
E-commerce
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increased use of new-generation drugs as one of the prime reasons driving the dravet syndrome treatment market growth during the next few years. Also, advances in biomedical sciences and strong pipeline will lead to sizable demand in the market.

The report on the dravet syndrome treatment market covers the following areas:

Dravet Syndrome Treatment Market sizing
Dravet Syndrome Treatment Market forecast
Dravet Syndrome Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dravet syndrome treatment market vendors that include AbbVie Inc., BIOCODEX SAS, Encoded Therapeutics Inc., Epygenix Therapeutics Inc., H Lundbeck AS, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., PTC Therapeutics Inc., Stoke Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., UCB SA, Viatris Inc., Xenon Pharmaceuticals Inc., and Zydus Lifesciences Ltd.. Also, the dravet syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Diagnostic Methods
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Dravet Syndrome Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Dravet Syndrome Treatment Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Diagnostic Methods segment analysis 2019 - 2023
- Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
5.4 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Dravet Syndrome Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 SGDs - Market size and forecast 2024-2029
- Chart on SGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on SGDs - Market size and forecast 2024-2029 ($ million)
- Chart on SGDs - Year-over-year growth 2024-2029 (%)
- Data Table on SGDs - Year-over-year growth 2024-2029 (%)
8.4 TGDs - Market size and forecast 2024-2029
- Chart on TGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on TGDs - Market size and forecast 2024-2029 ($ million)
- Chart on TGDs - Year-over-year growth 2024-2029 (%)
- Data Table on TGDs - Year-over-year growth 2024-2029 (%)
8.5 FGDs - Market size and forecast 2024-2029
- Chart on FGDs - Market size and forecast 2024-2029 ($ million)
- Data Table on FGDs - Market size and forecast 2024-2029 ($ million)
- Chart on FGDs - Year-over-year growth 2024-2029 (%)
- Data Table on FGDs - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Diagnostic Methods

9.1 Market segments
- Chart on Diagnostic Methods - Market share 2024-2029 (%)
- Data Table on Diagnostic Methods - Market share 2024-2029 (%)
9.2 Comparison by Diagnostic Methods
- Chart on Comparison by Diagnostic Methods
- Data Table on Comparison by Diagnostic Methods
9.3 Magnetic resonance imaging - Market size and forecast 2024-2029
- Chart on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
- Data Table on Magnetic resonance imaging - Market size and forecast 2024-2029 ($ million)
- Chart on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
- Data Table on Magnetic resonance imaging - Year-over-year growth 2024-2029 (%)
9.4 Electroencephalography - Market size and forecast 2024-2029
- Chart on Electroencephalography - Market size and forecast 2024-2029 ($ million)
- Data Table on Electroencephalography - Market size and forecast 2024-2029 ($ million)
- Chart on Electroencephalography - Year-over-year growth 2024-2029 (%)
- Data Table on Electroencephalography - Year-over-year growth 2024-2029 (%)
9.5 SCN1A genetic testing - Market size and forecast 2024-2029
- Chart on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
- Data Table on SCN1A genetic testing - Market size and forecast 2024-2029 ($ million)
- Chart on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
- Data Table on SCN1A genetic testing - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Diagnostic Methods
- Market opportunity by Diagnostic Methods ($ million)
- Data Table on Market opportunity by Diagnostic Methods ($ million)

10 Market Segmentation by Distribution Channel

10.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
10.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
10.3 Hospital pharmacy - Market size and forecast 2024-2029
- Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
10.4 Retail pharmacy - Market size and forecast 2024-2029
- Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
10.5 E-commerce - Market size and forecast 2024-2029
- Chart on E-commerce - Market size and forecast 2024-2029 ($ million)
- Data Table on E-commerce - Market size and forecast 2024-2029 ($ million)
- Chart on E-commerce - Year-over-year growth 2024-2029 (%)
- Data Table on E-commerce - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 BIOCODEX SAS
- BIOCODEX SAS - Overview
- BIOCODEX SAS - Product / Service
- BIOCODEX SAS - Key offerings
- SWOT
15.6 Encoded Therapeutics Inc.
- Encoded Therapeutics Inc. - Overview
- Encoded Therapeutics Inc. - Product / Service
- Encoded Therapeutics Inc. - Key offerings
- SWOT
15.7 Epygenix Therapeutics Inc.
- Epygenix Therapeutics Inc. - Overview
- Epygenix Therapeutics Inc. - Product / Service
- Epygenix Therapeutics Inc. - Key offerings
- SWOT
15.8 H Lundbeck AS
- H Lundbeck AS - Overview
- H Lundbeck AS - Product / Service
- H Lundbeck AS - Key offerings
- SWOT
15.9 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
15.10 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.11 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
15.12 PTC Therapeutics Inc.
- PTC Therapeutics Inc. - Overview
- PTC Therapeutics Inc. - Product / Service
- PTC Therapeutics Inc. - Key offerings
- SWOT
15.13 Stoke Therapeutics Inc.
- Stoke Therapeutics Inc. - Overview
- Stoke Therapeutics Inc. - Product / Service
- Stoke Therapeutics Inc. - Key offerings
- SWOT
15.14 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.15 Supernus Pharmaceuticals Inc.
- Supernus Pharmaceuticals Inc. - Overview
- Supernus Pharmaceuticals Inc. - Product / Service
- Supernus Pharmaceuticals Inc. - Key offerings
- SWOT
15.16 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.17 UCB SA
- UCB SA - Overview
- UCB SA - Product / Service
- UCB SA - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

ドラベ症候群治療の世界市場 2025～2029年

Global Dravet Syndrome Treatment Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製品別

第9章市場セグメンテーション：診断方法別

第10章市場セグメンテーション：流通チャネル別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Product

9 Market Segmentation by Diagnostic Methods

10 Market Segmentation by Distribution Channel

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

ドラベ症候群治療の世界市場 2025～2029年

Global Dravet Syndrome Treatment Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：製品別

第9章 市場セグメンテーション：診断方法別

第10章 市場セグメンテーション：流通チャネル別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Product

9 Market Segmentation by Diagnostic Methods

10 Market Segmentation by Distribution Channel

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：製品別

第9章市場セグメンテーション：診断方法別

第10章市場セグメンテーション：流通チャネル別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録